Toll-like Receptor Signaling Beyond Infection in Urinary Bladder Dysfunction: Molecular Insights and Therapeutic Implications

Lower urinary tract dysfunction is highly prevalent and imposes a substantial individual and societal burden. Yet, current pharmacotherapies offer only limited symptomatic relief and are constrained by adverse effects and poor adherence. Toll-like receptors (TLRs), and Toll-like receptor 4 (TLR4) in particular, are key pattern-recognition receptors of the innate immune system. Their role in bladder host defense against uropathogens is well established; more recently, however, the same receptors have been recognized as drivers of sterile, infection-independent inflammation by sensing endogenous damage-associated molecular patterns. This review focuses on that infection-independent role, synthesizing recent experimental evidence that implicates TLR signaling, acting largely through the NF-κB axis and its coupling to the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, in three major bladder disorders: interstitial cystitis/bladder pain syndrome (IC/BPS), bladder outlet obstruction (BOO), and diabetic bladder dysfunction (DBD). In IC/BPS, TLR4 mediates bladder pain independently of inflammation, while TLR7 has been implicated in the Hunner-type subtype; in BOO, TLR4 and TLR9 contribute to the early inflammatory phase of remodeling; and in DBD, TLR4 activation drives bladder hypertrophy and hypercontractility. Selective antagonists such as TAK-242 and inhibition of TLR4/NF-κB signaling attenuate these changes, identifying the pathway as a tractable therapeutic target. We concentrate on these three conditions because direct experimental evidence for TLR involvement is, to date, largely confined to them. Throughout, we distinguish human, animal, and ex vivo or cell-based findings, and we note that the supporting evidence remains most robust for IC/BPS and largely preliminary for BOO. We close by highlighting the field’s near-exclusive focus on TLR4 and the mechanistic and translational gaps that future studies must address.